Could VEGF‐D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism?-Reference-Cited by-同舟云学术

Could VEGF‐D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism?

Published:2021-07-14 Issue:10 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Kerget Buğra¹^ORCID,Erol Afşin Dursun²^ORCID,Aksakal Alperen²^ORCID,Kerget Ferhan³^ORCID,Aşkın Seda⁴^ORCID,Yılmazel Uçar Elif¹^ORCID,Sağlam Leyla¹^ORCID

Affiliation:

1. Department of Pulmonary Diseases Ataturk University School of Medicine Erzurum Turkey

2. Department of Pulmonary Diseases Health Sciences University Erzurum Regional Education and Research Hospital Erzurum Turkey

3. Department of Infection Diseases and Clinical Microbiology Health Sciences University Erzurum Regional Education and Research Hospital Erzurum Turkey

4. Department of Biochemistry Ataturk University School of Medicine Erzurum Turkey

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14601

Reference15 articles.

1. Deep vein thrombosis and pulmonary embolism

2. Acute pulmonary embolism: a concise review of diagnosis and management

3. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

4. Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?

5. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia‐inducible factor‐1α→ hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors;Tsuzuki Y;Can Res,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitive Marker Affected by All Systemic Abnormalities—troponine;The Eurasian Journal of Medicine;2023-01-18

2. Vascular endothelial growth factor and the risk of venous thromboembolism: a genetic correlation and two-sample Mendelian randomization study;Thrombosis Journal;2022-11-08

3. Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism;Clinical Biochemistry;2022-10

4. Levels of Vascular Endothelial Growth Factor and Its Association with Pulmonary Embolism in COVID-19;Journal of Interferon & Cytokine Research;2022-08-01

5. Incidence and Related Factors for Low-Extremity Deep Vein Thrombosis in Breast Cancer Patients Who Underwent Surgical Resection: What Do We Know and What Should We Care;Frontiers in Surgery;2022-02-04